Related Experiment Video
Updated: Aug 31, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and
Moein Shirzad1, Marjan Nourigorji1, Atefe Sajedi2
1Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Abstract:
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a highly pathogenic and transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 (COVID-19) can be severe, especially among high risk populations affected of underlying medical conditions. COVID-19 is characterized by the severe acute respiratory syndrome, a hyper inflammatory syndrome, vascular injury, microangiopathy and thrombosis. Antiviral drugs and immune modulating methods has been evaluated. So far, a particular therapeutic option has not been approved for COVID-19 and a variety of treatments have been studied for COVID-19 including, current treatment such as oxygen therapy, corticosteroids, antiviral agents until targeted therapy and vaccines which are diverse in each patient and have various outcomes. According to the findings of different in vitro and in vivo studies, some novel approach such as gene editing, cell based therapy, and immunotherapy may have significant potential in the treatment of COVID-19. Based on these findings, this paper aims to review the different strategies of treatment against COVID-19 and provide a summary from traditional and newer methods in curing COVID-19.
Insights
This review summarizes treatments for Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2. It covers traditional therapies and explores promising novel approaches like gene editing and immunotherapy for effective COVID-19 treatment.
Area of Science:
- Virology and Infectious Diseases
- Immunology
- Genetics
Background:
- Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19, a severe respiratory illness particularly dangerous for high-risk individuals.
- COVID-19 presents with severe respiratory distress, hyperinflammation, vascular damage, and thrombosis.
- Current treatment strategies for COVID-19 are diverse, ranging from supportive care to vaccines, with varied patient outcomes.
Purpose of the Study:
- To review and summarize various treatment strategies for COVID-19.
- To provide an overview of both established and emerging therapeutic approaches.
Main Methods:
- Literature review of in vitro and in vivo studies on COVID-19 treatments.
- Analysis of traditional and novel therapeutic methods.
Main Results:
- A wide array of treatments, including oxygen therapy, corticosteroids, and antivirals, have been investigated.
- Novel approaches such as gene editing, cell-based therapy, and immunotherapy show significant potential for treating COVID-19.
Conclusions:
- No single approved therapeutic option exists for COVID-19.
- Emerging therapies like gene editing, cell-based therapy, and immunotherapy offer promising avenues for future COVID-19 treatment development.
Related Concept Videos
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy

